compare glp 1 agonists GLP-1 receptor Comparative features of glucagon-like peptide
Description
10.1007/s12325-022-02153-x 42 KangX.WangD.ZhangL.HuangT.LiuS.FengX.et al (2023)
J Neurochem (2005) 92:798806
moderate renal impairment (eGFR 30-45 ml/min) has been observed to increase plasma levels of sitagliptin 2-fold, and severe renal impairment can increase plasma levels 4-fold
J Biol Chem., 283, 11340-7
Health system challenges, particularly in low-resource settings, include limited access to alternative therapies, lack of standardized guidelines, and sociocultural barriers to contraceptive use and pregnancy planning
